Andrew Hill1, Anna Garratt2, Jacob Levi3, Jonathan Falconer4, Leah Ellis5, Kaitlyn McCann5, Victoria Pilkington6, Ambar Qavi5, Junzheng Wang5, Hannah Wentzel5. 1. Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK. 2. Department of Infectious Diseases, University Hospital of Wales, Cardiff and Vale University Health Board, UK. 3. Department of Intensive Care, University College London Hospital, ULCH NHS Trust, London, UK. 4. Department of Infectious Diseases, Chelsea and Westminster Hospital, Imperial NHS Trust, London, UK. 5. Faculty of Medicine, Imperial College London, London, UK. 6. Oxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK.
Open Forum Infectious Diseases, ofab358, https://doi.org/10.1093/ofid/ofab358Published: 06 July 2021On July 6, 2021, Open Forum Infectious Diseases published the article
“Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection” by Hill, et
al. Subsequently, we and the authors have learned that one of the studies on which this
analysis was based has been withdrawn due to fraudulent data. The authors will be submitting a
revised version excluding this study, and the currently posted paper will be retracted.
Authors: Halie M Rando; Nils Wellhausen; Soumita Ghosh; Alexandra J Lee; Anna Ada Dattoli; Fengling Hu; James Brian Byrd; Diane N Rafizadeh; Ronan Lordan; Yanjun Qi; Yuchen Sun; Christian Brueffer; Jeffrey M Field; Marouen Ben Guebila; Nafisa M Jadavji; Ashwin N Skelly; Bharath Ramsundar; Jinhui Wang; Rishi Raj Goel; YoSon Park; Simina M Boca; Anthony Gitter; Casey S Greene Journal: mSystems Date: 2021-11-02 Impact factor: 6.496
Authors: Marcos Alejandro Mayer; Alejandro Krolewiecki; Alejandro Ferrero; Marcelo Bocchio; Juan Barbero; Marcos Miguel; Ariel Paladini; Carlos Delgado; Juan Ramón Ojeda; Claudia Elorza; Ana Bertone; Pedro Emanuel Fleitas; Gustavo Vera; Mario Rubén Kohan Journal: Front Public Health Date: 2022-02-22